EGF receptor targeting in therapy-resistant human tumors
- 1 February 2002
- journal article
- review article
- Published by Elsevier in Drug Resistance Updates
- Vol. 5 (1) , 11-18
- https://doi.org/10.1016/s1368-7646(02)00004-3
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- The 4-anilinoquinazoline class of inhibitors of the erbB family of receptor tyrosine kinasesPublished by Elsevier ,2001
- Stat3 as an OncogenePublished by Elsevier ,1999
- Unliganded Epidermal Growth Factor Receptor Dimerization Induced by Direct Interaction of Quinazolines with the ATP Binding SitePublished by Elsevier ,1997
- Abrogation of Cisplatin-Induced Programmed Cell Death in Human Breast Cancer Cells by Epidermal Growth Factor Antisense RNAJNCI Journal of the National Cancer Institute, 1997
- Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapyBritish Journal of Cancer, 1995
- EGF Receptor Deletions Define a Region Specifically Mediating Stat Transcription Factor ActivationBiochemical and Biophysical Research Communications, 1995
- Mechanisms of EGF receptor regulation in breast cancer cellsBreast Cancer Research and Treatment, 1994
- Antitumor Effects of Doxorubicin in Combination With Anti-epidermal Growth Factor Receptor Monoclonal AntibodiesJNCI Journal of the National Cancer Institute, 1993
- Prognostic value of epidermal growth factor receptor in a series of 303 breast cancersEuropean Journal Of Cancer, 1992
- Efficacy of Antibodies to Epidermal Growth Factor Receptor Against KB Carcinoma In Vitro and in Nude MiceJNCI Journal of the National Cancer Institute, 1988